publication . Article . Other literature type . 2018

Healthy weight and obesity prevention: JACC Health Promotion Series

Lavie, Carl J.; Laddu, Deepika; Arena, Ross; Ortega, Francisco B.; Alpert, Martin A.; Kushner, Robert F.;
Open Access English
  • Published: 01 Sep 2018
  • Publisher: ELSEVIER
  • Country: Spain
Abstract
Overweight and obesity have reached epidemic levels in the United States and worldwide, and this has contributed to substantial cardiovascular and other health risks. However, controversy exists concerning the causes of obesity and effective modalities for its prevention and treatment. There is also controversy related to the concept of metabolically healthy obesity phenotype, the “obesity paradox,” and on the importance of fitness to protect individuals who are overweight or obese from cardiovascular diseases. In this state-of-the-art review, the authors focus on “healthy weight” with the emphasis on the pathophysiologic effects of weight gain on the cardiovasc...
Subjects
free text keywords: Cardiovascular diseases, Healthy weight, Obesity, Cardiology, medicine.medical_specialty, medicine, Diabetes mellitus, medicine.disease, Health promotion, Weight gain, medicine.symptom, Gerontology, Obesity paradox, Weight loss, Internal medicine, business.industry, business, Metabolically healthy obesity, Overweight
Funded by
EC| CoCA
Project
CoCA
Comorbid Conditions of Attention deficit / hyperactivity disorder
  • Funder: European Commission (EC)
  • Project Code: 667302
  • Funding stream: H2020 | RIA
103 references, page 1 of 7

1. Lavie CJ, Arena R, Alpert MA, Milani RV, Ventura HO. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol 2018;15:45-56.

2. Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis: the obesity paradox updated. Prog Cardiovasc Dis 2016;58:537-47.

3. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 2018;319: 1723-5.

4. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012;31:219-30.

5. Cawley J, Rizzo JA, Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med 2007;49: 1317-24.

6. Gates D, Succop P, Brehm B, Gillespie GL, Sommers BD. Obesity and presenteeism: the impact of body mass index on workplace productivity. J Occup Environ Med 2008;50:39-45. [OpenAIRE]

7. Lavie CJ, Sharma A, Alpert MA, et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 2016;58:393-400.

8. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res 2016;118:1752-70.

9. World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8-11 December 2008. Geneva, Switzerland: World Health Organization, 2011. Available at: http://www.who.int/iris/ handle/10665/44583. Accessed June 1, 2018.

10. Turco JV, Inath-Veith A, Fuster V. Cardiovascular health promotion: an issue that can no longer wait. J Am Coll Cardiol 2018;72:908-13.

11. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 2014;56:391-400.

12. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations and management. Transl Res 2014;164:345-56.

13. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4:436-43.

14. Sung JK, Kim JY. Obesity and preclinical changes of cardiac geometry and function. Korean Circ J 2010;40:55-61. [OpenAIRE]

15. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976;60:645-53. [OpenAIRE]

103 references, page 1 of 7
Abstract
Overweight and obesity have reached epidemic levels in the United States and worldwide, and this has contributed to substantial cardiovascular and other health risks. However, controversy exists concerning the causes of obesity and effective modalities for its prevention and treatment. There is also controversy related to the concept of metabolically healthy obesity phenotype, the “obesity paradox,” and on the importance of fitness to protect individuals who are overweight or obese from cardiovascular diseases. In this state-of-the-art review, the authors focus on “healthy weight” with the emphasis on the pathophysiologic effects of weight gain on the cardiovasc...
Subjects
free text keywords: Cardiovascular diseases, Healthy weight, Obesity, Cardiology, medicine.medical_specialty, medicine, Diabetes mellitus, medicine.disease, Health promotion, Weight gain, medicine.symptom, Gerontology, Obesity paradox, Weight loss, Internal medicine, business.industry, business, Metabolically healthy obesity, Overweight
Funded by
EC| CoCA
Project
CoCA
Comorbid Conditions of Attention deficit / hyperactivity disorder
  • Funder: European Commission (EC)
  • Project Code: 667302
  • Funding stream: H2020 | RIA
103 references, page 1 of 7

1. Lavie CJ, Arena R, Alpert MA, Milani RV, Ventura HO. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol 2018;15:45-56.

2. Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis: the obesity paradox updated. Prog Cardiovasc Dis 2016;58:537-47.

3. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 2018;319: 1723-5.

4. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012;31:219-30.

5. Cawley J, Rizzo JA, Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med 2007;49: 1317-24.

6. Gates D, Succop P, Brehm B, Gillespie GL, Sommers BD. Obesity and presenteeism: the impact of body mass index on workplace productivity. J Occup Environ Med 2008;50:39-45. [OpenAIRE]

7. Lavie CJ, Sharma A, Alpert MA, et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 2016;58:393-400.

8. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res 2016;118:1752-70.

9. World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8-11 December 2008. Geneva, Switzerland: World Health Organization, 2011. Available at: http://www.who.int/iris/ handle/10665/44583. Accessed June 1, 2018.

10. Turco JV, Inath-Veith A, Fuster V. Cardiovascular health promotion: an issue that can no longer wait. J Am Coll Cardiol 2018;72:908-13.

11. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis 2014;56:391-400.

12. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations and management. Transl Res 2014;164:345-56.

13. Wong C, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med 2007;4:436-43.

14. Sung JK, Kim JY. Obesity and preclinical changes of cardiac geometry and function. Korean Circ J 2010;40:55-61. [OpenAIRE]

15. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976;60:645-53. [OpenAIRE]

103 references, page 1 of 7
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue